- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 137.1M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.57B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.53B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $400.26M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $400.06M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.14B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.2B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.55B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.48B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.65B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.51B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 139.87M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $500M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $71.44M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $40.05M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $5.15B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $5.11B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $4.52 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $4.55 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $442.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | $632.22M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $254.21M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $697.19M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.19B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.88B |